A detailed history of Baillie Gifford & CO transactions in Neogen Corp stock. As of the latest transaction made, Baillie Gifford & CO holds 11,227,219 shares of NEOG stock, worth $135 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
11,227,219
Previous 11,580,986 3.05%
Holding current value
$135 Million
Previous $181 Million 4.26%
% of portfolio
0.14%
Previous 0.14%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$14.73 - $17.71 $5.21 Million - $6.27 Million
-353,767 Reduced 3.05%
11,227,219 $189 Million
Q2 2024

Jul 25, 2024

SELL
$11.61 - $17.01 $2.42 Million - $3.55 Million
-208,535 Reduced 1.77%
11,580,986 $181 Million
Q1 2024

May 01, 2024

BUY
$15.0 - $20.35 $52.5 Million - $71.3 Million
3,502,807 Added 42.27%
11,789,521 $186 Million
Q4 2023

Jan 26, 2024

BUY
$14.65 - $20.7 $121 Million - $172 Million
8,286,714 New
8,286,714 $167 Million

Others Institutions Holding NEOG

About NEOGEN CORP


  • Ticker NEOG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 216,108,000
  • Market Cap $2.6B
  • Description
  • Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal f...
More about NEOG
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.